Voranigo is a first-in-class, FDA-approved medicine used to treat adults
and children 12 years & older with Grade 2 astrocytoma or
oligodendroglioma with an isocitrate dehydrogenase-1 (IDH1) or
isocitrate dehydrogenase-2 (IDH2) mutation. Voranigo offers patients the
ability to actively manage their disease with a once-daily pill.
ALZpath’s proprietary phosphorylated tau (pTau217) antibody, powers
highly sensitive, convenient and scalable blood tests, to detect minute
concentrations of pTau217, a hallmark of Alzheimer’s disease, aiding
early diagnosis before symptoms appear. This supports early detection,
trial initiation and treatment monitoring to improve patient outcomes.
The “BrainProbe,” developed by Professor Albert Yang, is an innovative
platform leveraging explainable deep learning and cloud-based interfaces
to assess and diagnose neuropsychiatric disorders. It enables precise
tracking of brain region degeneration over time and identifies targeted
regions for personalized brain stimulation therapies.
Water utilities are struggling to comply with PFAS mandates. The
Transcend Design Generator eliminates uncertainty on how utilities and
engineering consultants plan and design PFAS treatment systems. By
automating the engineering of these projects, stakeholders have full
visibility into project costs & timelines in minutes – not years.
Kind Designs is revolutionizing coastal protection with 3D-printed
Living Seawalls™. By leveraging advanced 3D printing technology, Kind
Designs transforms traditional coastal infrastructure into thriving
aquatic habitats. Biomimetic Living Seawalls™ replicate natural coastal
systems to foster marine biodiversity and provide robust coastal
defense.
An autonomous tunnel inspection system leverages UGV-UAV collaboration
and AI technologies to achieve 360° full inspection coverage, cm-level
real-time positioning accuracy in GPS-denied environments, and instant
AI detection for mm-level defects. It offers fully digitalized
inspection reports and remote system control from an off-site office.
With this sensing system, concrete pavement won’t need to be repaired as
often and roads could open sooner after a fresh pour. The sensors are
tossed into a concrete pour and plugged into a handheld device that logs
concrete strength data. An app shows the concrete’s strength levels in
real time to convey when pavement is strong enough for traffic.
Transcend Design Generator automatically generates unique, optimized
designs of electrical substation facilities by combining project
specific inputs with AI-led decision making. Engineering firms,
utilities, and equipment vendors can reduce engineering costs, win more
work, and become more profitable.
Advanced electronics are not possible without ultrapure materials.
ELECPURE™ is a new, patented, purification technology that removes
>30 metal ion types to parts per TRILLION levels with >90% less
energy. ELECPURE™ can be used in photoresists, color resists, or
cleaners. ELECPURE™ improves yields, device performance and enables next
gen devices.
Glaucoma is the second leading cause of blindness. Revolutionary
glaucoma drug ITRI-E-(S)4046, administered in eye drops, lowers
intraocular pressure three times more than current medication by
targeting two enzymes simultaneously. Unlike conventional drugs, this
treatment requires just one application per day, reducing side effects.